Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

10x Genomics (TXG) Tax Provisions (2018 - 2025)

Historic Tax Provisions for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $1.1 million.

  • 10x Genomics' Tax Provisions rose 6342.59% to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 million, marking a year-over-year decrease of 2618.23%. This contributed to the annual value of $3.6 million for FY2025, which is 2618.23% down from last year.
  • Per 10x Genomics' latest filing, its Tax Provisions stood at $1.1 million for Q4 2025, which was up 6342.59% from -$733000.0 recorded in Q3 2025.
  • 10x Genomics' 5-year Tax Provisions high stood at $2.5 million for Q2 2025, and its period low was -$733000.0 during Q3 2025.
  • For the 5-year period, 10x Genomics' Tax Provisions averaged around $1.2 million, with its median value being $1.1 million (2023).
  • In the last 5 years, 10x Genomics' Tax Provisions skyrocketed by 25927.34% in 2022 and then crashed by 15574.14% in 2025.
  • Over the past 5 years, 10x Genomics' Tax Provisions (Quarter) stood at $2.5 million in 2021, then crashed by 67.26% to $804000.0 in 2022, then surged by 192.79% to $2.4 million in 2023, then plummeted by 72.47% to $648000.0 in 2024, then surged by 63.43% to $1.1 million in 2025.
  • Its Tax Provisions was $1.1 million in Q4 2025, compared to -$733000.0 in Q3 2025 and $2.5 million in Q2 2025.